ArticleAlzheimer's & dementia (Amsterdam, Netherlands)
A virtual reality cognitive screening tool based on the six cognitive domains.
Article in Alzheimer's & dementia (Amsterdam, Netherlands). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Virtual Reality Gamification of Visual Search, Response Inhibition, and Visual Short-Term Memory Tasks for Cognitive Assessment: Experimental Study.JMIR formative research · 2025Trial
- Virtual reality for opioid reduction in postoperative cardiac and thoracic surgery: A randomized controlled trial protocol.MethodsX · 2026Article
- A smart secure virtual reality immersive application for alzheimer's and dementia patients.Scientific reports · 2025Article
- A virtual reality cognitive screening tool based on the six cognitive domains.Alzheimer's & dementia (Amsterdam, Netherlands)Article
- The use of fully immersive virtual reality for screening neurodegenerative diseases: A systematic review of behavioral and diagnostic outcomes.Alzheimer's & dementia (Amsterdam, Netherlands)Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionEarly detection of cognitive impairment enables interventions to slow cognitive decline. Existing neuropsychological paper-and-pencil tests may not adequately assess cognition in real-life environments. A fully-immersive and automated virtual reality (VR) system-Cognitive Assessment using VIrtual REality (CAVIRE)-was developed to assess all six cognitive domains. This case-control study aims to evaluate the ability of CAVIRE to differentiate cognitively-healthy individuals from those with cognitive impairment.
methodsOne hundred nine Asian individuals 65-84 years of age were recruited at a primary care setting in Singapore. Based on the Montreal Cognitive Assessment (MoCA), participants were grouped as either Cognitively Healthy (MoCA ≥26,
resultsCognitively-healthy participants achieved higher VR scores and required shorter completion time across all six cognitive domains (all DISCUSSION: The results demonstrated the potential of CAVIRE as a cognitive screening tool in primary care. Highlights: CAVIRE is a virtual reality (VR) system that assesses the six cognitive domains.CAVIRE can distinguish healthy individuals from individuals with cognitive impairment.It has potential as a cognitive screening tool for older people in primary care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.